Ryan Logue
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,205 | 376 | 93.4% |
| Education | $432.79 | 8 | 4.9% |
| Travel and Lodging | $144.28 | 1 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,495 | 60 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,300 | 65 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $859.01 | 38 | $0 (2024) |
| GENZYME CORPORATION | $851.65 | 37 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $629.42 | 24 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $549.16 | 22 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $408.07 | 19 | $0 (2024) |
| Grifols USA, LLC | $308.84 | 16 | $0 (2024) |
| Insmed, Inc. | $234.57 | 13 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $206.13 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,991 | 172 | AstraZeneca Pharmaceuticals LP ($802.50) |
| 2023 | $3,590 | 158 | GlaxoSmithKline, LLC. ($694.96) |
| 2022 | $986.24 | 46 | GENZYME CORPORATION ($179.69) |
| 2021 | $87.34 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($41.00) |
| 2020 | $127.60 | 5 | Advanced Respiratory, Inc ($68.68) |
All Payment Transactions
385 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: RESPIRATORY | ||||||
| 12/20/2024 | Regeneron Healthcare Solutions, Inc. | — | Food and Beverage | In-kind items and services | $120.83 | General |
| 12/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $30.60 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: Pulmonology | ||||||
| 12/16/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Pulmonology | ||||||
| 12/12/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: Cardiology | ||||||
| 12/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $126.42 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Inflammation | ||||||
| 12/09/2024 | Merck Sharp & Dohme LLC | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/06/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $16.13 | General |
| Category: Medical Device | ||||||
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.43 | General |
| 11/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/08/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.67 | General |
| 11/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $10.48 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $28.52 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $30.49 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $117.90 | General |
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Education | In-kind items and services | $23.32 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Education | In-kind items and services | $21.72 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 893 | 1,349 | $241,242 | $97,516 |
| 2022 | 8 | 170 | 316 | $64,790 | $25,716 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 137 | 337 | $36,733 | $19,098 | 52.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 50 | 116 | $53,476 | $17,446 | 32.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 67 | 187 | $52,460 | $16,488 | 31.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 125 | 177 | $31,571 | $15,394 | 48.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 68 | 68 | $16,932 | $7,569 | 44.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 55 | 57 | $17,499 | $6,852 | 39.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 52 | 54 | $8,802 | $4,599 | 52.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 27 | 30 | $6,900 | $3,985 | 57.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 39 | 39 | $8,112 | $3,678 | 45.3% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 79 | 79 | $2,291 | $708.63 | 30.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 84 | 85 | $3,230 | $651.10 | 20.2% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 81 | 81 | $1,782 | $536.22 | 30.1% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 18 | 22 | $1,012 | $282.24 | 27.9% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 11 | 17 | $442.00 | $230.69 | 52.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 28 | 72 | $33,192 | $11,660 | 35.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 57 | 145 | $15,805 | $7,563 | 47.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 23 | 23 | $5,727 | $2,849 | 49.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 20 | $3,260 | $1,907 | 58.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 11 | 19 | $5,700 | $1,445 | 25.4% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 12 | 12 | $348.00 | $109.56 | 31.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 13 | 13 | $494.00 | $101.40 | 20.5% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 12 | 12 | $264.00 | $80.88 | 30.6% |
About Ryan Logue
Ryan Logue is a Student in an Organized Health Care Education/Training Program healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/01/2016. The National Provider Identifier (NPI) number assigned to this provider is 1093178477.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ryan Logue has received a total of $8,782 in payments from pharmaceutical and medical device companies, with $3,991 received in 2024. These payments were reported across 385 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($8,205).
As a Medicare-enrolled provider, Logue has provided services to 1,063 Medicare beneficiaries, totaling 1,665 services with total Medicare billing of $123,232. Data is available for 2 years (2022–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Pulmonary Disease
- Location Indianapolis, IN
- Active Since 04/01/2016
- Last Updated 07/22/2024
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1093178477
Products in Payments
- DUPIXENT (Biological) $1,296
- TEZSPIRE (Biological) $757.51
- TRELEGY ELLIPTA (Drug) $621.35
- OPSUMIT (Drug) $599.64
- OFEV (Drug) $592.80
- NUCALA (Biological) $560.53
- GLASSIA (Biological) $400.84
- Prolastin-C Liquid (Biological) $294.40
- BREZTRI (Drug) $259.06
- Arikayce (Drug) $234.57
- FASENRA (Biological) $218.99
- XARELTO (Drug) $206.13
- NA (Device) $198.93
- YUPELRI (Drug) $179.60
- FLOWTRIEVER CATHETER, S (Device) $177.74
- AIRSUPRA (Drug) $136.19
- TYVASO (Drug) $130.62
- STIOLTO RESPIMAT (Drug) $130.52
- LOKELMA (Drug) $99.18
- ACTHAR (Biological) $89.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Indianapolis
Kevin Trulock, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $246,254
Nikolajs Perdue, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $221,939
Christopher Healy
Student in an Organized Health Care Education/Training Program — Payments: $113,924
Dr. Eric Orman, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $70,877
Dustin Holland, M.d., M.p.h, M.D., M.P.H
Student in an Organized Health Care Education/Training Program — Payments: $38,628
Dr. Ashish Pulikal, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $34,359